跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XIFAXAN rifaximin 550 mg tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
XIFAXAN rifaximin 550 mg tablet blister pack
Approved
STANDARD
XIFAXAN rifaximin 550 mg tablet blister pack
Norgine Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
5b1e89ae37fdd2d8
Company
Norgine Pty Ltd
Type
Standard
Approval Details
Approval Id
5b1e89ae37fdd2d8
Product Name
XIFAXAN rifaximin 550 mg tablet blister pack
Artg Id
183411
Artg Name
XIFAXAN rifaximin 550 mg tablet blister pack
Sponsor
Norgine Pty Ltd
Company Detail Path
/organization/laurus-generics-sa-pty-ltd
Artg Date
2012-05-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2017-CMI-02283-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2012-PI-02052-3
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
5b1e89ae37fdd2d8
Type
Standard
Back to TGA Approvals